INOMAX® Important Safety Information
INOMAX is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Please see Full Prescribing Information.
Learn more about the breadth of support and services you can count on with INOMAX Total Care®.
Download a PDF of this presentation
View the tutorial